These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2102308)

  • 21. [Results of postoperative radiotherapy with iridium-192 in patients with ovarian cancer].
    Krauss T; Meden H; Rath W; Kuhn W
    Zentralbl Gynakol; 1992; 114(12):603-5. PubMed ID: 1285484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
    Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
    Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The detection of ovarian cancer using 123J monoclonal antibody.
    Granowska M; Britton KE; Shepherd J
    Radiobiol Radiother (Berl); 1984; 25(1):153-60. PubMed ID: 6729079
    [No Abstract]   [Full Text] [Related]  

  • 24. Killer antibodies enter clinical trial against ovarian cancer.
    Kerkvliet GJ
    J Natl Cancer Inst; 1990 Apr; 82(7):549-50. PubMed ID: 2313732
    [No Abstract]   [Full Text] [Related]  

  • 25. 111In-CYT-103 immunoscintigraphy in ovarian cancer.
    Cannistra SA
    Gynecol Oncol; 1993 Nov; 51(2):292-4. PubMed ID: 8276314
    [No Abstract]   [Full Text] [Related]  

  • 26. Ovarian cancer: diagnosis using 123I monoclonal antibody in comparison with surgical findings.
    Granowska M; Shepherd J; Britton KE; Ward B; Mather S; Taylor-Papadimitriou J; Epenetos AA; Carroll MJ; Nimmon CC; Hawkins LA
    Nucl Med Commun; 1984 Aug; 5(8):485-99. PubMed ID: 6533499
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibody-guided irradiation of malignant lesions: three cases illustrating a new method of treatment. A report from the Hammersmith Oncology Group and the Imperial Cancer Research Fund.
    Lancet; 1984 Jun; 1(8392):1441-3. PubMed ID: 6145882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immunobiology and immunotherapy of ovarian cancer.
    Bookman MA; Bast RC
    Semin Oncol; 1991 Jun; 18(3):270-91. PubMed ID: 1710393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic intraperitoneal 32P: a clinical assessment of the dynamics of distribution.
    Kaplan WD; Zimmerman RE; Bloomer WD; Knapp RC; Adelstein SJ
    Radiology; 1981 Mar; 138(3):683-8. PubMed ID: 7465847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Guidelines for external radiotherapy and brachytherapy: introduction to the 2nd edition. Société française de radiothérapie oncologique (SFRO)].
    Mahé MA; Barillot I; Chauvet B
    Cancer Radiother; 2014 Oct; 18(5-6):356-9. PubMed ID: 25199866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Common epithelial cancer of the ovary (2).
    Richardson GS; Scully RE; Nikrui N; Nelson JH
    N Engl J Med; 1985 Feb; 312(8):474-83. PubMed ID: 3881673
    [No Abstract]   [Full Text] [Related]  

  • 32. Biologic therapy for ovarian cancer.
    Bookman MA
    Curr Opin Oncol; 1989 Oct; 1(1):112-8. PubMed ID: 2489941
    [No Abstract]   [Full Text] [Related]  

  • 33. [Standards, options, and recommendations for the radiotherapy of patients with endometrial cancer. FNCLCC (National Federation of Cancer Campaign Centers) and CRLCC (Regional Cancer Campaign Centers)].
    Thomas L; Bataillard A; Brémond A; Fondrinier E; Fervers B; Achard JL; Lansac J; Bailly C; Hoffstetter S; Basuyau JP; d'Anjou J; Descamps P; Farsi F; Guastalla JP; Laffargue F; Rodier JF; Vincent P; Pigneux J
    Cancer Radiother; 2001 Apr; 5(2):163-92. PubMed ID: 11355582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rational combinations of immunotherapy with radiotherapy in ovarian cancer.
    Herrera FG; Irving M; Kandalaft LE; Coukos G
    Lancet Oncol; 2019 Aug; 20(8):e417-e433. PubMed ID: 31364594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early results of the monoclonal antibody OVTL3 in specific detection of ovarian cancer.
    Epenetos AA; Lavender JP; Kenemans P; Poels L
    J Clin Oncol; 1987 Jan; 5(1):160. PubMed ID: 3806157
    [No Abstract]   [Full Text] [Related]  

  • 36. Radiation therapy in the treatment of patients with cancer of the ovary.
    Bush RS
    Bull N Y Acad Med; 1983 Oct; 59(8):691-710. PubMed ID: 6357333
    [No Abstract]   [Full Text] [Related]  

  • 37. [REGAJ diagnosis of recurrence of ovarian cancer].
    Paterok EM; Jäger W; Feistel H; Lang N; Wolf F
    Gynakol Rundsch; 1989; 29 Suppl 2():360-3. PubMed ID: 2613050
    [No Abstract]   [Full Text] [Related]  

  • 38. Radioisotopes in treatment of stage Ia ovarian cancer.
    Buchsbaum HJ; Keettel WC
    Natl Cancer Inst Monogr; 1975 Oct; 42():127-8. PubMed ID: 1234628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunopharmacokinetics of 111In-CYT-103 in ovarian cancer patients.
    Jusko WJ; Kung LP; Schmelter RF
    Targeted Diagn Ther; 1992; 6():177-90. PubMed ID: 1576345
    [No Abstract]   [Full Text] [Related]  

  • 40. Antitumor antibodies for immunotherapy of ovarian carcinomas.
    Wagner U
    Hybridoma; 1993 Oct; 12(5):521-8. PubMed ID: 8300125
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.